SKLB-Y13
SKLB-Y13 is a selective inhibitor of YTHDF1 with an IC50 of 0.76 μM. It binds to the m6A recognition pocket, disrupting the m6A-dependent YTHDF1-PRPF6 mRNA interaction, which impairs the translation of PRPF6, inhibits breast cancer cell proliferation, and promotes apoptosis. SKLB-Y13 exhibits antitumor activity, holding potential for targeted RNA epigenetic cancer therapy.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6188781-01 0.1 mL
AHNAK (Neuroblast Differentiation-associated Protein AHNAK, Desmoyokin, PM227, MGC5395) (MaxLight 405)
Sign In for Pricing
View Details MBS6188781-02 5x 0.1 mL
AHNAK (Neuroblast Differentiation-associated Protein AHNAK, Desmoyokin, PM227, MGC5395) (MaxLight 405)
Sign In for Pricing
View Details 
OM623969 96 Strip Well
Bovine Xylosyltransferase 2 (XYLT2) ELISA Kit
Sign In for Pricing
View Details MBS1441413-01 0.02 mg (E-Coli)
Recombinant Shewanella putrefaciens Na (+)-translocating NADH-quinone reductase subunit F (nqrF)
Sign In for Pricing
View Details MBS1441413-02 0.02 mg (Yeast)
Recombinant Shewanella putrefaciens Na (+)-translocating NADH-quinone reductase subunit F (nqrF)
Sign In for Pricing
View Details